Aventis Pharma (formerly Hoechst Marion Roussel) is investigating the ketolides HMR-3562 and HMR-3787 as potential antibacterial agents. The compounds belong to a series of 2-fluoroketolides. They have exhibited potency against a range of gram-positive bacteria and other respiratory tract pathogens including Haemophilus influenzae in vitro and in vivo.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
aventis pharma
8
hmr-3562 aventis
4
pharma aventis
4
pharma hoechst
4
hoechst marion
4
marion roussel
4
roussel investigating
4
investigating ketolides
4
ketolides hmr-3562
4
hmr-3562 hmr-3787
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!